MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics, Inc. (ELTX)

|||

Balance Sheets Overview

Current Ratio
276.95%
Quick Ratio
276.95%
Cash Ratio
255.16%
Debt to Asset Ratio
74.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease, right-of-use as...
    • Other long-term prepaid assets
    • Restricted cash, noncurrent
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term debt, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
23,480
14,948
18,563
20,611
Restricted cash, current
-
-
0
0
Prepaid expenses and other current assets
2,005
1,252
748
854
Total current assets
25,485
16,200
19,311
21,465
Property and equipment, net
213
249
295
328
Operating lease, right-of-use assets
4,292
4,539
4,782
5,019
Restricted cash, noncurrent
515
706
704
702
Other long-term prepaid assets
825
995
770
770
Total assets
31,330
22,689
25,862
28,284
Accounts payable
839
272
672
321
Accrued expenses
7,290
5,915
6,427
5,213
Deferred research obligation
-
-
0
0
Operating lease liability, current
1,073
1,042
1,011
981
Total current liabilities
9,202
7,229
8,110
6,515
Warrant liabilities
1,116
3,599
2,615
3,877
Operating lease liability, noncurrent
3,540
3,823
4,094
4,356
Long-term debt, net
9,535
9,475
9,407
9,720
Total liabilities
23,393
24,126
24,226
24,468
Common stock, 0.01 par value per share 300,000,000 shares authorized 21,916,024 shares and 17,814,762 shares issued at june30, 2026 and december31, 2025, respectively 21,901,569 and 17,800,307 outstanding as of june30, 2026 and december31, 2025, respectively
219
186
178
173
Treasury stock, at cost, 14,455 shares outstanding
150
150
150
150
Additional paid-in capital
261,706
244,144
235,407
229,778
Accumulated other comprehensive loss
-126
-122
-127
-31
Accumulated deficit
-253,712
-245,495
-233,672
-225,954
Total stockholders' equity
7,937
-1,437
1,636
3,816
Total liabilities and stockholders' equity
31,330
22,689
25,862
28,284
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$23,480K (6.30%↑ Y/Y)Prepaid expenses andother current assets$2,005K (293.14%↑ Y/Y)Total current assets$25,485K (12.78%↑ Y/Y)Operating lease,right-of-use assets$4,292K (-18.29%↓ Y/Y)Other long-termprepaid assets$825K (37.50%↑ Y/Y)Restricted cash,noncurrent$515K (-26.43%↓ Y/Y)Property and equipment,net$213K (-43.50%↓ Y/Y)Total assets$31,330K (6.10%↑ Y/Y)Total liabilities andstockholders' equity$31,330K (6.10%↑ Y/Y)Total liabilities$23,393K (-15.53%↓ Y/Y)Total stockholders'equity$7,937K (332.77%↑ Y/Y)Accumulated deficit-$253,712K (-17.53%↓ Y/Y)Treasury stock, at cost,14,455 shares...$150K (0.00%↑ Y/Y)Accumulated othercomprehensive loss-$126K (-80.00%↓ Y/Y)Long-term debt, net$9,535K (2.12%↑ Y/Y)Total currentliabilities$9,202K (-7.27%↓ Y/Y)Operating leaseliability, noncurrent$3,540K (-23.26%↓ Y/Y)Warrant liabilities$1,116K (-70.79%↓ Y/Y)Additional paid-in capital$261,706K (20.18%↑ Y/Y)Common stock, 0.01 parvalue per share...$219K (34.36%↑ Y/Y)Accrued expenses$7,290K (42.77%↑ Y/Y)Operating leaseliability, current$1,073K (212.71%↑ Y/Y)Accounts payable$839K (-78.29%↓ Y/Y)